title: Osteoprotegerin serum levels in primary hyperparathyroidism and changes following surgery.
authors.affiliation: Department of Internal Medicine and Medical Disciplines, "Sapienza" Rome University, Rome, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Minisola
authors.affiliation: Department of Internal Medicine and Medical Disciplines, "Sapienza" Rome University, Rome, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Cipriani
authors.affiliation: Department of Internal Medicine and Medical Disciplines, "Sapienza" Rome University, Rome, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Piemonte
authors.affiliation: Department of Internal Medicine and Medical Disciplines, "Sapienza" Rome University, Rome, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Colangelo
authors.affiliation: Department of Internal Medicine and Medical Disciplines, "Sapienza" Rome University, Rome, Italy.
authors.forename: J
authors.initials: J
authors.lastname: Pepe
authors.affiliation: Department of Internal Medicine and Medical Disciplines, "Sapienza" Rome University, Rome, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Romagnoli
mesh_terms: D019386:Alendronate / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D016723:Bone Remodeling; D005260:Female; D006801:Humans; D049950:Hyperparathyroidism, Primary / Q000628:therapy*; D008297:Male; D053244:Osteoprotegerin / Q000097:blood*; D053245:RANK Ligand / Q000097:blood*
chemical_list: D050071:Bone Density Conservation Agents; D053244:Osteoprotegerin; D053245:RANK Ligand; D019386:Alendronate